BioDelivery Sciences International, Inc.
CIK 0001103021
Revenue (TTM)
$162.99M
+295.3% YoY
FY Mar 2022
Net Income (TTM)
$31.17M
+230.1% YoY
FY Mar 2022
EPS Diluted (TTM)
$0.30
+720.0% YoY
FY Mar 2022
Gross Margin
20.8%
FY Mar 2022
Operating Margin
24.3%
FY Mar 2022
Net Margin
19.1%
FY Mar 2022
Free Cash Flow (TTM)
$7.39M
FY Mar 2022
Cash
$114.3M
FY Mar 2022
Total Debt
—
FY Mar 2022
Shares Outstanding
103.23M sh
FY Mar 2022